The effect of dapagliflozin on apolipoprotein B and glucose fluxes in patients with type 2 diabetes and well‐controlled plasma LDL cholesterol - Concepedia

Concepedia

Publication | Open Access

The effect of dapagliflozin on apolipoprotein B and glucose fluxes in patients with type 2 diabetes and well‐controlled plasma LDL cholesterol

DOI Full Paper Access

12

Citations

25

References

2020

Year

Kristien E. Bouter, Erik J.M. van Bommel, Hans Jansen, Dewi van Harskamp, Henk Schierbeek, Mariëtte T. Ackermans, Mireille J. Serlie, Alinda W.M. Schimmel, Max Nieuwdorp, Geesje M. Dallinga‐Thie,

Diabetes Obesity and Metabolism

Abstract

Dapagliflozin has no effect on plasma LDL-cholesterol levels or VLDL-apoB fluxes in the context of optimal lipid-lowering treatment, which will thus not limit cardiovascular benefit when lipids are adequately controlled.

References

	Year	Citations

Page 1